Skip to content
Search

Latest Stories

Morrison: Pharmacy contract news “before the start of the financial year”

Morrison: Pharmacy contract news

Janet Morrison


Community pharmacies will get clarity over a new funding contract before the start of the financial year, according to Community Pharmacy England (CPE) chief executive Janet Morrison.


Yesterday, the National Pharmacy Association (NPA) announced that it will advise its members to go on collective action from April 1st which will see a reduction in opening hours and services.

The NPA said it had taken the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

The government said the move would cause "unnecessary disruption for patients" and a settlement with pharmacies was already being worked on.

The CPE, which negotiates the pharmacy contract with NHS England, said today it was aware of the urgent need for pharmacists to know the funding they will receive.

“As well as additional funding, pharmacy owners desperately need clarity about the future; many are already making impossible decisions to help their businesses to survive and to protect patients,” said Morrison.

“All CPE Committee Members are fully aware of the sector’s urgent need for funding and of the need to resolve negotiations as robustly and speedily as possible to secure the best outcomes for pharmacy owners.

“We are not able to give a running commentary on negotiations, but as the Secretary of State commented to Parliament last week – negotiations are ‘about to conclude’. It remains our goal to communicate with the sector as soon as possible, and before the start of the financial year.”

Pharmacies have seen around a 40 per cent cut to this funding in real terms since 2017, forcing record numbers to close. 29 have shut since the beginning of the year, with around 1,300 pharmacies shutting since 2017.

Around 90 per cent of an average pharmacy's work is funded via the NHS, including dispensing medication and vaccinations. But although the end of the current financial year is just days away pharmacies are yet to receive any confirmation of funding for either the 2024/25 or 25/26 financial years that might allow them to avoid service reductions.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less